Healio: Driver training software program associated with fewer distractions in ADHD youth
Healio highlighted a recent trial published by University of Cincinnati and Cincinnati Children's Hospital Medical Center researchers that found a driver training software program reduced how often adolescent drivers with ADHD took long glances away from the roadway.
Led by Jeffery N. Epstein, PhD, professor in UC's Department of Pediatrics in the College of Medicine, director of the Cincinnati Children's Center for ADHD and a pediatric psychologist, the research was published in the New England Journal of Medicine.
Teenage drivers with ADHD are twice as likely than neurotypical teens to be in an accident, the researchers wrote, noting a struggle for these teens to sustain visual attention while driving.
In the trial, the researchers evaluated the effectiveness of an enhanced version of the Focused Concentration and Attention Learning (FOCAL+) program, a desktop-based software program that features multiple sessions and simulator training "with immediate auditory feedback" designed to reduce long glances away from the road of 2 seconds or longer.
The teen drivers with ADHD randomly assigned to the FOCAL+ program were found to have significantly fewer long glances from the roadway.
Featured photo at top courtesy of Unsplash.
Related Stories
Parakeet males, females equally likely to fight
September 14, 2026
Researchers from the University of Cincinnati and Duke University studied captive monk parakeets and found that sex has little effect on who starts fights, who is targeted or who rises in the dominance hierarchy, as reported in Integrative & Comparative Biology.
UC researchers seek to combat youth weight gain from bipolar medication
September 14, 2026
Cleveland.com highlighted a University of Cincinnati initiative approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to expand the implementation of healthy lifestyle interventions and metformin prescription to help manage weight gain in overweight or obese youth taking second-generation antipsychotic medications.